The 6 Most Interesting Behavioral Health Deals of 2024 — So Far

Dealmaking in the behavioral health space is slow these days — there’s no arguing that. But there are still plenty of lessons to be learned from the deals that have been completed thus far in 2024. With less to look at, there’s more to see. With fewer deals, we can spend more time taking in […]

Psychedelics Too Trippy for FDA, But There Still May Be a Role in Behavioral Health Care

Late last week, the psychedelics industry received its latest blow when the FDA shot down Lykos Therapeutics’ application for MDMA-assisted therapy for treating PTSD. Many in the psychedelics industry had hailed Lykos Therapeutics’ treatment as the pioneer for regulatory clearance. However, the FDA sent the pharma company back to the drawing board for more testing, […]

8 SUD Treatment Companies to Watch in 2024

The substance use disorder (SUD) treatment industry has experienced significant challenges and breakthroughs in 2024, but a handful of providers are emerging as ones to watch in the coming year. The SUD dealmaking space has stayed stale thus far in 2024. While deals once flowed freely, only 10 closed in the first half of the […]

Autism Therapy Execs ‘Had to Learn the Hard Way’ Relationships Are Crucial for Successful Treatment

The autism therapy industry needs to continue its strategic and cultural evolution. That goes for all its constituents — providers, payers and investors alike. This evolution has been ongoing to varied degrees for years now. The expansion of the industry through private investment accelerated it. Today, the industry must take care to ensure an ethical […]

10 Behavioral Health Companies to Watch for a Potential Sale

Dealmaking in the behavioral health space has been slower in recent years. However, a handful of notable companies could be changing hands in the not-so-distant future. Based on data from the first quarter, it appears behavioral health dealmaking is stuck at lower volumes than pre-pandemic levels. As we prepare for new batches of M&A data […]

‘Diversity Can’t Be An Afterthought’: How Behavioral Health Providers Should Approach the Clinician Workforce

Patients and providers want to see representation when they engage with the behavioral health care industry. Historically, that has been a challenge as the behavioral health workforce continues to under represent minority communities. That makes hiring and retaining a diverse clinical workforce a daunting but vital task for organizations seeking to improve the health of […]

Behavioral Health Enters ‘Uncertainty Era’ After Chevron Doctrine Ends

The U.S. Supreme Court has handed the behavioral health industry a bag of uncertainty with the elimination of the decade’s old Chevron doctrine. The removal of the Chevron doctrine, a high-profile legal decision, makes it easier for behavioral health providers to poke holes in state and federal rules that rely on regulatory agencies’ interpretations of […]

The Next Chapter for Mental Health Coverage and Business Models

All was relatively quiet on the behavioral health front for publicly traded companies in Q1, reflecting the typically sleepy nature of the first quarter for those seeking to wrap up old initiatives and start new ones. Don’t get me wrong: It’s not like nothing happened or there isn’t anything worth pondering. Quite the opposite, in […]